US FDA’s Overloaded Advanced Therapies Office Eyes Organizational, Communication Changes

 
• By Sue Sutter
  
Tree branches
Some of the branches of FDA's Office of Tissues and Advanced Therapies have grown so large they are unmanageable. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies